Cafepharma Today

May 15 2025 - FDA approves Amneal's self-administered migraine treatment
FDA approves Amneal's self-administered migraine treatment
VC firm reveals plan for 30K-square-foot biotech incubator space in New Jersey
Philips taps Nvidia to build AI model for MRI
FDA delays decision on Biohaven's rare disease drug filing, plans adcomm
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Weakening Outlook on Sanofi
Yahoo/Zacks.com
Tuesday, February 16, 2010 - 5:10pm
tags:
Sanofi
For Blockbuster Cancer Drugs, Approvals Are the Easy Part
Motley Fool
Tuesday, February 16, 2010 - 3:26pm
tags:
cancer, Pfizer, Sanofi, JNJ, Doxil, Gleevac, Novartis, Lyrica, Erbitux
ImClone Scandal: A Timeline
TheStreet.com
Tuesday, February 16, 2010 - 2:25pm
tags:
ImClone, Eli Lilly, Pfizer, Bristol-Myers Squibb
Rigel Investors Balk at AstraZeneca Deal
Minyanville
Tuesday, February 16, 2010 - 2:24pm
tags:
Rigel, AstraZeneca, partnerships
A Big Upgrade for Vical
Motley Fool
Tuesday, February 16, 2010 - 2:23pm
tags:
Vical
Merck to Slash 15% of Workforce, Save up to $3B - CBL
Citybizlist
Tuesday, February 16, 2010 - 11:01am
tags:
Merck, restructuring, layoffs
Pharma aims its brands at emerging markets
Fierce Pharma
Tuesday, February 16, 2010 - 10:52am
tags:
generics, emerging markets
Commonly used diabetes drug metformin stinks, literally, and this may explain why many patients stop taking it, U.S. doctors reported on Monday
Reuters
Tuesday, February 16, 2010 - 10:51am
tags:
metformin, diabetes
Affymax Targets Amgen Anemia Drug Aided by U.S. Rules
Bloomberg
Tuesday, February 16, 2010 - 10:47am
tags:
Amgen, anemia, Affymax, Epogen
Path to Surfaxin approval looks less costly for Discovery Labs after FDA guidance
Bizjournals.com
Tuesday, February 16, 2010 - 10:46am
tags:
Surfaxin, FDA, Discovery Labs
Quintiles Expands Stake in Big Pharma
NY Times, NY
Tuesday, February 16, 2010 - 10:44am
tags:
Quintiles, Eli Lilly, FDA
Abbott Completes Acquisition of Solvay Pharmaceuticals
Yahoo
Tuesday, February 16, 2010 - 10:44am
tags:
Abbott Laboratories, Solvay, M&A
ImClone Founder Waksal Forming New Biotech Venture
TheStreet.com
Tuesday, February 16, 2010 - 10:38am
tags:
insider trading, ImClone, Kadmon
The Medicines Company of Parsippany to cut 26% of its U.S. sales force
NJ.com
Tuesday, February 16, 2010 - 10:37am
tags:
layoffs, Medicines Company
GSK to increase headcount, introduce more products in India
Hindu Business Line, India
Tuesday, February 16, 2010 - 10:30am
tags:
India, GSK
AstraZeneca to pay Rigel up to $1.25 billion in arthritis pact
Marketwatch
Tuesday, February 16, 2010 - 10:28am
tags:
Rigel, AstraZeneca, arthritis, partnerships
Pfizer Suit May Open Skeleton-Filled Closet on Side Effects of Cholesterol Drug Lipitor
BNET Pharma
Tuesday, February 16, 2010 - 10:26am
tags:
Pfizer, lawsuits, Lipitor, whistleblowers
FDA asks Amgen, J&J to discuss anemia drug risks
Yahoo/AP
Tuesday, February 16, 2010 - 10:23am
tags:
JNJ, Amgen, FDA, anemia, Aranesp, Procrit, Epogen
Merck Profit Rises More Than Analysts Estimated
Bloomberg
Tuesday, February 16, 2010 - 9:46am
tags:
Merck, earnings
Botox May Reduce Migraine Headaches Described as ‘Eye-Popping’
Bloomberg
Tuesday, February 16, 2010 - 9:45am
tags:
Botox, Allergan, migraines

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline
The GLP-1 Saga Continues, And How
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.